Zynext Ventures, the VC arm of Zydus Lifesciences, Announces Investment in Promaxo: Pioneering Point-of-Care Medical Imaging and Interventions with Next Generation MRI Systems | Placera
Summary
Amit Vohra , Founder and CEO of Promaxo, expressed his enthusiasm: "We are thrilled to partner with Zynext Ventures and leverage their extensive expertise in the healthcare sector. "Their innovative technology aligns perfectly with Zynexts mission of investing in disruptive new-age healthcare solutions that elevate patient outcomes. The group employs 26,000 people worldwide, including 1,400 scientists engaged in R & D, and is driven by its mission to unlock new possibilities in lifesciences through quality healthcare solutions that impact lives. Over the last decade, Zydus has introduced several innovative, first-in-class products in the market for treating unmet healthcare needs with vaccines, therapeutics, biologicals and biosimilars. Based in Oakland, California , and backed by over 200 patents, the Companys mission is to improve lives through state-of-the-art medical imaging, robotics and AI capabilities.